Some will know I’m one of those who threw in the towel on the 670G after several months of struggle. In fact I went back to my old Paradigm pump b/c as a strictly manual pump it’s simpler and more robust than the 670, now languishing in its box in my Emergency Backup Supplies drawer. I’m about to upgrade to Dexcom G6, and in light of what I’m hearing about Tandem’s X2, it occurred to me to wonder, if I did want to buy one out of pocket, how much would that cost. So I went to the Tandem site, and lo, this was being publicized:
If you are currently using a non-Tandem pump for your insulin therapy and are interested in upgrading to the t:slim X2 Insulin Pump with Basal-IQ Technology, you have the option to use a new t:slim X2 Pump for the remainder of your current pump warranty for a one-time payment of $999.
Not a whole lot of “non-Tandem” pumps to choose from these days—hard not to conclude this is targeted directly at people in the exact same situation as me: unhappy 670 users who are stuck with a pump that didn’t, for them, live up to its promises, for another 3-4 years. $1k is not cheap, but I might could swing it. Hmmm…
In any case, it seems to be a pretty clear indication that Tandem is reading the user reviews and seeing a weakness to exploit. I truly don’t intend this as a Medtronic-bashing thread; the 670 has a lot of users who are thrilled with it as well. But as for me, well, yay competition.